Completed NA INTERVENTIONAL 2-arm NCT03014115

Effects of Different ARA Formulations of Infant Formula on Fatty Acid Status, Immune Markers and Infection Rates in Infants

EFFECTS OF DIFFERENT ARA FORMULATIONS OF INFANT FORMULA ON FATTY ACID STATUS, IMMUNE MARKERS AND INFECTION RATES IN INFANTS

Sponsor: SynteractHCR

Conditions Healthy Infants

Interventions DHA combination ARA + DHA

Updated 9 times since 2017 Last updated: Jan 14, 2020 Started: Nov 30, 2016 Primary completion: May 31, 2019 Completion: Aug 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Healthy Infants and is currently completed. SynteractHCR leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Mar 2026 — Present [monthly]

Completed NA
Sep 2024 — Mar 2026 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA

Status: Active Not Recruiting → Completed

▶ Show 4 earlier versions

Sep 2018 — Feb 2020 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jun 2018 — Sep 2018 [monthly]

Recruiting NA
Feb 2018 — Jun 2018 [monthly]

Recruiting NA
Feb 2017 — Feb 2018 [monthly]

Recruiting NA

First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

SynteractHCR
dsm-firmenich Switzerland AG

Data source: dsm-firmenich Switzerland AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain